nach oben

Erschienen in:

01.10.2011 | Case Report

Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion

verfasst von: Hideki Nakamura, Keiko Hisatomi, Tomohiro Koga, Akinari Mizokami, Satoshi Yamasaki, Mami Tamai, Tomoki Origuchi, Junji Irie, Atsushi Kawakami

Erschienen in: Modern Rheumatology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

A 68-year-old woman was admitted with bleary eyes and lacrimal gland swelling. A biopsy specimen from a right paravertebral mass lesion detected by computed tomography showed remarkable IgG4-positive plasma cells. Because serum IgG4 was elevated to 3300 mg/dl, IgG4-related disease was diagnosed, with the assistance of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT). Administration of 30 mg of oral prednisolone effectively reduced the lacrimal gland swelling and paravertebral mass volume. Nine months after the initiation of prednisolone, serum IgG4 was reduced to 31.4 mg/dl, and there was norecurrence.

Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:3948–55.PubMedCrossRef

Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev. 2010;9:591–4.PubMedCrossRef

Haraguchi A, Era A, Yasui J, Ando T, Ueki I, Horie I, et al. Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J. 2010;57:719–25.PubMedCrossRef

Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz’s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol. 2010;37:1380–5.PubMedCrossRef

Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310–5.PubMedCrossRef

Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57–66.PubMedCrossRef

Kawakami H, Zen Y, Kuwatani M, Eto K, Haba S, Yamato H, Shinada K, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.PubMedCrossRef

Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:88–94.PubMedCrossRef

Ishida M, Hotta M, Kushima R, Asai T, Okabe H. IgG4-related inflammatory aneurysm of the aortic arch. Pathol Int. 2009;59:269–73.PubMedCrossRef

10.

Naitoh I, Nakazawa T, Ohara H, Ando T, Hayashi K, Tanaka H. IgG4-related hepatic inflammatory pseudotumor with sclerosing cholangitis: a case report and review of the literature. Cases J. 2009;2:7029.PubMedCrossRef

11.

Nakamura H, Wada H, Origuchi T, Kawakami A, Taura N, Aramaki T, et al. A case of IgG4-related autoimmune disease with multiple organ involvement. Scand J Rheumatol. 2006;35:69–71.PubMedCrossRef

12.

Fujiu K, Sakuma H, Miyamoto H, Yamaguchi B. Immunoglobulin G4-related inflammatory pseudotumor of the lung. Gen Thorac Cardiovasc Surg. 2010;58:144–8.PubMedCrossRef

13.

Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol. 2009;23:339–53.PubMedCrossRef

14.

Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241–51.PubMedCrossRef

Titel: Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion
verfasst von: Hideki Nakamura
Keiko Hisatomi
Tomohiro Koga
Akinari Mizokami
Satoshi Yamasaki
Mami Tamai
Tomoki Origuchi
Junji Irie
Atsushi Kawakami
Publikationsdatum: 01.10.2011
Verlag: Springer Japan
Erschienen in: Modern Rheumatology / Ausgabe 5/2011
Print ISSN: 1439-7595
Elektronische ISSN: 1439-7609
DOI: https://doi.org/10.1007/s10165-011-0427-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2011

Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life

A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea

A case of juvenile idiopathic arthritis exhibiting repair of systemic bone erosion in response to continuation of MTX therapy after achievement of clinical remission

Successful treatment of cyclosporine-A-resistant cytophagic histiocytic panniculitis with tacrolimus

Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial

Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin